The group includes MKT-077 and YM-01, which have been investigated for anti-AD activity as they may provoke Hsp70-mediated decline in pathological tau content in vitro (Abisambra et al., 2013; Martin et al., 2016). This evidence concerns the gene MAPT and Alzheimer disease.